Fosfomycin Trometamolium

磷霉素氨丁三醇

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameFosfomycin Trometamolium
Drug Alias NameFosfomycin trometamolFosbretabulin tromethamineMonurolMonuril美乐力 +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitors
TargetsUDP-N-acetylglucosamine 1-carboxyvinyltransferase
Therapy Area/IndicationsCystitisProstatitisUrinary Bladder Neoplasms +[4] 
Global Approved IndicationsUrinary Tract Infections
Approved Indications in ChinaUrinary Tract Infections
Original Approved Country/TerritoryN/A
Original Approved Date1988/01/01
Country/TerritoryUnited StatesMexicoAustralia +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZambon
China Registration ClassN/A

Develop Information

Active CompaniesInstituto Nacional De Ciencias Medicas Y Nutricion Salvador ZubiranZambonDepartment of General Practice, Rouen University +[4] 
Inactive CompaniesZambon Spa
Active IndicationsCystitisProstatitisUrinary Bladder Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01XX01
Related LinksWikipediaDrugBankKEGG